A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/1999
12/16/1999	WO1999063940A2 INHIBITORS OF H+K+-ATPase
12/16/1999	WO1999063937A2 Multivalent macrolide antibiotics
12/16/1999	WO1999063929A2 Multibinding inhibitors of microsomal triglyceride transferase protein
12/16/1999	WO1999056700A3 Avian polyomavirus vaccines in psittacine birds
12/16/1999	WO1999055348A3 Stabilised virus preparation
12/16/1999	WO1999054354A9 Sp22, a fertility-associated protein from sperm and a method for evaluating and affecting male fertility using it
12/16/1999	WO1999052947A3 TRANSFERRIN RECEPTOR GENES OF $i(MORAXELLA)
12/16/1999	WO1999052546A3 A method of inducing an anti-tumor response against a lung metastasis in a melanoma patient
12/16/1999	WO1999049017A3 Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgroup b
12/16/1999	WO1999045120A3 Attenuation of bacteria: materials and methods relating thereto
12/16/1999	WO1999041373A3 Human transport-associated molecules
12/16/1999	WO1999041368A3 Optimization of immunomodulatory properties of genetic vaccines
12/16/1999	WO1999029865A3 A protein belonging to the tnf superfamily, nucleic acids encoding same, and methods of use thereof
12/16/1999	CA2334895A1 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
12/16/1999	CA2334850A1 Novel methods and interferon deficient substrates for the propagation of viruses
12/16/1999	CA2334471A1 Antibodies to cytokines in the prevention and treatment of inflammatory bowel disease
12/16/1999	CA2332993A1 Phagocytic assay method
12/16/1999	CA2331378A1 Vaccination strategy to prevent and treat cancers
12/16/1999	CA2331372A1 Tankyrase, a trfi binding protein
12/16/1999	CA2330240A1 Moraxella catarrhalis pilq proteins
12/16/1999	CA2330238A1 Vaccine
12/16/1999	CA2330230A1 Herpes simplex virus origin binding protein n-terminal truncation (obp-nt)
12/16/1999	CA2330211A1 Formulations for electroporation
12/16/1999	CA2329942A1 Therapeutic and diagnostic domain 1 .beta.2gpi polypeptides and methods of using same
12/16/1999	CA2329685A1 Proteins regulating gene expression
12/16/1999	CA2329682A1 Moraxella catarrhalis polynucleotides and polypeptides
12/16/1999	CA2328906A1 Acrosomal sperm protein and uses thereof
12/16/1999	CA2328498A1 Monoclonal antibodies, cross-reactive antibodies and method for producing the same____________________________________
12/16/1999	CA2321274A1 Novel antiviral compounds
12/16/1999	CA2321191A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-ht3 receptors
12/16/1999	CA2321190A1 Novel therapeutic agents that modulate enzymatic processes
12/16/1999	CA2321166A1 Multibinding inhibitors of topoisomerase
12/16/1999	CA2321162A1 Novel antibacterial compounds
12/16/1999	CA2320241A1 Multivalent macrolide antibiotics
12/16/1999	CA2319730A1 Bradykinin antagonists
12/16/1999	CA2319495A1 Multibinding inhibitors of microsomal triglyceride transferase protein
12/16/1999	CA2319477A1 Inhibitors of h+k+-atpase
12/16/1999	CA2319474A1 Inhibitors of nitric oxide synthase
12/16/1999	CA2319174A1 Novel therapeutic agents that modulate 5-ht receptors
12/16/1999	CA2319120A1 Phosphodiesterase-v modulator drugs and their uses
12/16/1999	CA2318901A1 Novel calcium channel drugs and uses
12/16/1999	CA2316999A1 Inhibitors of hiv reverse transcriptase
12/16/1999	CA2315883A1 Muscarinic receptor antagonists
12/16/1999	CA2299678A1 Tgf.beta. rii receptor nucleic sequence, coded peptide, and uses
12/16/1999	CA2240779A1 Porcine reproductive and respiratory syndrome virus (prrsv) dna vaccines
12/15/1999	EP0963440A1 Improved methods for transducing cells
12/15/1999	EP0963431A1 NOVEL FabH
12/15/1999	EP0963377A1 Interleukin-19
12/15/1999	EP0963205A1 T1 receptor-like ligand ii
12/15/1999	EP0623167B1 Preparation of mystery disease virus antigens and vaccines and antigens and vaccines produced for the prevention of this disease
12/15/1999	CN1238783A Method and novel compounds for use therein
12/15/1999	CN1238697A Use of melanoma differentiation associated gene (mda 7) for reversing cancerous phenotype
12/15/1999	CN1238696A Vaccines
12/15/1999	CN1238693A Pharmaceutical composition comprising compound having anti-Xa activity and platelet aggregation antagonist compound
12/15/1999	CN1047402C Process for producing synthetic gene of encoding polyporus seed storage albumen
12/14/1999	US6001987 Isolated nucleotide sequences associated with Multiple sclerosis
12/14/1999	US6001972 Splicing variant of the epstein-barr virus-induced G-protein coupled receptor
12/14/1999	US6001802 Antiproliferative agents
12/14/1999	US6001651 Antisense modulation of LFA-3
12/14/1999	US6001644 Mammalian transformation complex comprising a lipid carrier and DNA encoding CFTR
12/14/1999	US6001634 Recombinant negative strand RNA viruses
12/14/1999	US6001623 Polynucleotide sequence coding a human enzymatic polypeptide; for developing treatments and diagnostic assays for disease
12/14/1999	US6001603 Polynucleotide sequence coding for a staphylococcus enzmatic protein; for diagnosis, treatment and prevention of bacterial infections; bactericides
12/14/1999	US6001602 DNA encoding Chlamydia trachomatis isoleucyl tRNA synthetase polypeptides
12/14/1999	US6001601 Methionyl tRNA synthetase polynucleotides
12/14/1999	US6001599 Nucleotide sequences coding zona pellucida protein; for the isolation of nucleic acid sequences coding human zona pellucida protein; antifertility agents
12/14/1999	US6001596 Growth-associated protease inhibitor heavy chain precursor
12/14/1999	US6001581 Cation-based bioassay using human metabotropic glutamate receptors
12/14/1999	US6001395 Polymeric lamellar substrate particles for drug delivery
12/14/1999	US6001372 Can be used to stimulate antigenic responses and to diagnose the presence of the bacteria
12/14/1999	US6001371 Relates to recombinant baculoviruses encoding parvovirus structural proteins and host cells infected therewith; method of packaging and delivering genetic information utilizing the noninfectious capsids
12/14/1999	US6001370 New attenuated strain allows the obtaining of vaccines and diagnostic kits which make possible both the early diagnosis of porcine reproductive respiratory syndrome and an efficient preventive treatment of such disease
12/14/1999	US6001369 Recombinant fowlpox virus comprising a foreign dna inserted into the fowlpox virus genomic dna, wherein the foreign dna sequence is inserted within a fragment of the fowlpox virus genomic dna and is capable of being expressed in host cell
12/14/1999	US6001363 Eimeria protein with immunogenic properties; dna encoding this protein can be used for the preparation of a vector vaccine against coccidiosis
12/14/1999	US6001362 Treatment of an individual in need of response regulator polypeptide comprising administering to the individual a therapeutically effective amount of a polypeptide comprising given amino acid sequence
12/14/1999	US6001361 For the prevention, treatment and diagnosis of mycobacterial infection, together with adjuvants for use in vaccines or immunotherapy of infectious diseases and cancers; for preventing, treating and detecting tuberculosis
12/14/1999	US6001360 Glutamic acid decarboxylase (gad) proteins and fragments thereof are administered to an animal in order to the reduce the severity of diabetes
12/14/1999	US6001358 Useful for treatment of autoimmune diseases
12/14/1999	US6001357 Method of enhancing wound healing with anti-IL-5 antibody
12/14/1999	US6001349 Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof
12/14/1999	US6001348 An nad (nicotinamide-adenine dinucleotide)-independent live attenuated strain of mycoplasma synoviae; and less expensive vaccines for protecting poultry against mycoplasma synoviae
12/14/1999	US6001347 Organic acid compound of given structure having an aromatic amide group, a methoxy group in the ortho position on the aromatic ring, and a lipophilic chain terminated with a carboxylic acid is useful as a nontoxic carrier
12/14/1999	CA2135642C Tat-derived transport polypeptides
12/14/1999	CA2095642C Adhesion receptors for pathogenic or opportunistic microorganisms
12/14/1999	CA2081028C Cd2 binding domain of lymphocyte function associated antigen 3
12/14/1999	CA2051808C Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same
12/14/1999	CA1340848C Pseudorabies virus protein
12/14/1999	CA1340847C Adhesin antigens
12/09/1999	WO1999063098A1 Recombinant venezuelan equine encephalitis virus vaccine
12/09/1999	WO1999063095A1 Nucleic acid vaccines for prevention of flavivirus infection
12/09/1999	WO1999063093A2 Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
12/09/1999	WO1999063084A1 T cell antigen receptor sequences specific to arthrosis deformans
12/09/1999	WO1999063079A1 Endometriosis-associated gene
12/09/1999	WO1999063063A1 Cellular proteins which mediate herpesvirus entry
12/09/1999	WO1999063050A2 Method for preparation and in vivo administration of antigen presenting cell composition
12/09/1999	WO1999062942A2 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
12/09/1999	WO1999062941A2 Serpentine transmembrane antigens expressed in human cancers and uses thereof
12/09/1999	WO1999062939A2 Glycoproteins having lipid mobilising properties and therapeutic applications thereof
12/09/1999	WO1999062938A2 Polypeptides, traditionally of the human herpes virus type 8 and the diagnostic and medical application thereof
12/09/1999	WO1999062932A2 INHIBITION OF VIRAL INFECTION AND SPREAD WITH VIRAL AND RhoA-DERIVED PEPTIDES

1 ... 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 ... 1823